Every New Year begins with the best of intentions. Read on for specialized info for those on the gluten-free diet to take your health to the next level in 2015 (plus tips to help these changes stick!) Maximize Your Health with Naturally Gluten-Free Foods There’s no need for expensive gluten-free health products that boast claims that seem too…
On January 1, 2015 Celiac Disease Foundation launched its first Strategic Plan for the Years 2015-2018. Adopted unanimously by the CDF Board of Directors in December 2014, the Strategic Plan sets out the vision, mission and strategic priorities of the Foundation, building on the core operating values and assumptions underlying the Foundation’s approach to its mission. Executive Service Corps of…
On Tuesday, December 16, Congress reinstated the Charitable IRA Rollover provision retroactively for 2014 and extended it only through December 31, 2014. Originally enacted in 2006, the Charitable IRA Rollover allows individuals age 70½ and older to make direct transfers up to $100,000 per year from individual retirement accounts to qualified charities without having to count the transfers as income…
As we reflect on this past year, we want to thank you for your generous support, which has enabled us to achieve important advances in each of our key mission areas. CDF launched an Online Advocacy Program in order to encourage the public to bring celiac disease to the forefront of the nation’s healthcare agenda. We also unveiled a series of online tools, including a Symptoms & Conditions Checklist, a Healthcare Practitioner Directory, and a 7 Day Gluten-Free Meal Plan to aid in the diagnosis and treatment of celiac disease. Additionally, CDF provided a comprehensive didactic seminar at the National Education Conference this past June when Medical Directors from Alvine Pharmaceuticals, Quest Diagnostics, and LabCorp joined together for a biopharma panel to present information about advances in the screening and treatment of celiac disease.
Not long ago, the gluten-free lifestyle was reserved for people with celiac disease — a genetic autoimmune disorder in which the ingestion of gluten causes severe intestinal damage — who were forced to give up their favorite dishes and settle for strange, unappetizing foods. There are numerous reasons a person might choose to eat gluten-free,…
Amazon is now a proud sponsor of Celiac Disease Foundation (CDF), a national nonprofit organization dedicated to driving diagnosis and treatment of celiac disease through advocacy, education, and advancing research to improve the quality of life for all people affected by gluten-related disorders. Celiac disease, a genetic autoimmune disorder in which the ingestion of…
By Ellen Barlow Mass General Hospital’s Alessio Fasano, MD, has transformed conventional thinking about autoimmune diseases. Alessio Fasano, MD, is everywhere these days. The renowned head of the MGH Center for Celiac Research and Treatment has been in the news clarifying misconceptions about the gluten-free diet, at seminars demonstrating with finesse how to cook a…
All of a sudden, they seem to be everywhere: gluten-free options in grocery stores, restaurants, coffee bars, and even at the ballpark. Please, don’t get me wrong…all of this is great. What isn’t penetrating America’s consciousness, however, is the life-threatening implications of our ongoing failure to quickly and correctly diagnose and treat celiac…
The U.S. Preventative Services Task Force (USPSTF) has posted its research plan for the screening of the U.S. population for celiac disease. The research plan is designed to answer seven key questions about screening. These questions are: What is the effectiveness of screening versus not screening for celiac disease in asymptomatic adults, adolescents, or…
Celiac disease remains one of the most common autoimmune diseases, affecting approximately 1% of the population in the United States. Celiac disease is genetic; having a first degree relative with it means you are about ten times more likely to develop the disease. However, almost one third of the U.S. population has the genetic components…
Last month, the Celiac Disease Foundation had the privilege of sponsoring the 2024 International Celiac Disease Symposium in Sheffield, UK. As the first patient advocate invited to chair and present on a scientific panel, CEO Marilyn Geller co-chaired the End Points in Clinical Trials session with Dr. Francisco Leon, CEO...